67 related articles for article (PubMed ID: 17892927)
1. Intra-arterial and systemic chemotherapy plus external hyperthermia in unresectable biliary cancer.
Mambrini A; Del Freo A; Pacetti P; Orlandi M; Torri T; Fiorentini G; Cantore M
Clin Oncol (R Coll Radiol); 2007 Dec; 19(10):805-6. PubMed ID: 17892927
[No Abstract] [Full Text] [Related]
2. Capecitabine plus hepatic intra-arterial epirubicin and cisplatin in unresectable biliary cancer: a phase II study.
Mambrini A; Guglielmi A; Pacetti P; Iacono C; Torri T; Auci A; Nicoli N; Orlandi M; Guadagni S; Fiorentini G; Cantore M
Anticancer Res; 2007; 27(4C):3009-13. PubMed ID: 17695488
[TBL] [Abstract][Full Text] [Related]
3. Phase II study of hepatic intraarterial epirubicin and cisplatin, with systemic 5-fluorouracil in patients with unresectable biliary tract tumors.
Cantore M; Mambrini A; Fiorentini G; Rabbi C; Zamagni D; Caudana R; Pennucci C; Sanguinetti F; Lombardi M; Nicoli N
Cancer; 2005 Apr; 103(7):1402-7. PubMed ID: 15726542
[TBL] [Abstract][Full Text] [Related]
4. Single nucleotide polymorphisms and clinical outcome in patients with biliary tract carcinoma treated with epirubicin, cisplatin and capecitabine.
Pacetti P; Giovannetti E; Mambrini A; Nannizzi S; Orlandi M; Tartarini R; Del Freo A; Del Tacca M; Danesi R; Cantore M
Anticancer Res; 2009 May; 29(5):1835-40. PubMed ID: 19443413
[TBL] [Abstract][Full Text] [Related]
5. Phase II study of capecitabine and cisplatin in previously untreated advanced biliary tract cancer.
Hong YS; Lee J; Lee SC; Hwang IG; Choi SH; Heo JS; Park JO; Park YS; Lim HY; Kang WK
Cancer Chemother Pharmacol; 2007 Aug; 60(3):321-8. PubMed ID: 17143602
[TBL] [Abstract][Full Text] [Related]
6. [Hepatic arterial chemotherapy combined with hyperthermia or arterial embolization in unresectable liver tumor].
Hamazoe R; Koga S; Maeda M; Shimizu N; Shimizu T; Sawata T; Ishiguro M; Inoue Y; Wakatsuki T; Murakami A
Gan To Kagaku Ryoho; 1988 Aug; 15(8 Pt 2):2590-5. PubMed ID: 2843128
[TBL] [Abstract][Full Text] [Related]
7. Systemic gemcitabine and capecitabine plus intra-arterial epirubicin and cisplatin as second-line chemotherapy in gemcitabine-failure pancreatic cancer.
Mambrini A; Bassi C; Torri T; Orlandi M; Fiorentini G; Cantore M
Pancreas; 2011 Aug; 40(6):983-4. PubMed ID: 21562443
[No Abstract] [Full Text] [Related]
8. Regional combined with systemic chemotherapy in unresectable biliary tract cancers: a phase II study.
Cantore M; Fiorentini G; Mambrini A; Rabbi C; Zamagni D; Carlone N; Manni A; Caudana R; Torri T
J Exp Clin Cancer Res; 2003 Dec; 22(4 Suppl):59-64. PubMed ID: 16767908
[TBL] [Abstract][Full Text] [Related]
9. Regional chemotherapy in biliary tract cancers--a single institution experience.
Melichar B; Cerman J; Dvorák J; Jandík P; Mergancová J; Melicharová K; Tousková M; Krajina A; Voboril Z
Hepatogastroenterology; 2002; 49(46):900-6. PubMed ID: 12143237
[TBL] [Abstract][Full Text] [Related]
10. [A prospective randomized clinical trial comparing intra-arterial chemotherapy alone and when combined with hyperthermia for metastatic liver cancer].
Kondo M; Itani K; Yoshikawa T; Tanaka Y; Watanabe N; Hiraoka M; Noguchi M; Miura K
Gan To Kagaku Ryoho; 1995 Oct; 22(12):1807-11. PubMed ID: 7574814
[TBL] [Abstract][Full Text] [Related]
11. Phase II study of epirubicin, cisplatin, and capecitabine for advanced biliary tract adenocarcinoma.
Park SH; Park YH; Lee JN; Bang SM; Cho EK; Shin DB; Lee JH
Cancer; 2006 Jan; 106(2):361-5. PubMed ID: 16342166
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic efficacy of multimodal combination therapy using transcatheter arterial infusion of epirubicin and cisplatin, systemic infusion of 5-fluorouracil, and additional percutaneous ethanol injection for unresectable hepatocellular carcinoma.
Jang JW; Park YM; Bae SH; Choi JY; Yoon SK; Chang UI; Nam SW; Kim BS
Cancer Chemother Pharmacol; 2004 Nov; 54(5):415-20. PubMed ID: 15235823
[TBL] [Abstract][Full Text] [Related]
13. Phase II study of cisplatin, epirubicin, and continuous-infusion 5-fluorouracil for advanced biliary tract cancer.
Morizane C; Okada S; Okusaka T; Ueno H; Saisho T
Oncology; 2003; 64(4):475-6. PubMed ID: 12759549
[No Abstract] [Full Text] [Related]
14. Randomized prospective phase II study to compare the combination chemotherapy regimen epirubicin, cisplatin, and 5-fluorouracil with epirubicin, cisplatin, and capecitabine in patients with advanced or metastatic gastric cancer.
Ocvirk J; Reberšek M; Skof E; Hlebanja Z; Boc M
Am J Clin Oncol; 2012 Jun; 35(3):237-41. PubMed ID: 21399488
[TBL] [Abstract][Full Text] [Related]
15. Chemotherapy for biliary tract cancer in Japan.
Okusaka T
Semin Oncol; 2002 Dec; 29(6 Suppl 20):51-3. PubMed ID: 12577234
[TBL] [Abstract][Full Text] [Related]
16. A randomised phase II study of combination chemotherapy with epirubicin, cisplatin and capecitabine (ECX) or cisplatin and capecitabine (CX) in advanced gastric cancer.
Yun J; Lee J; Park SH; Park JO; Park YS; Lim HY; Kang WK
Eur J Cancer; 2010 Mar; 46(5):885-91. PubMed ID: 20060288
[TBL] [Abstract][Full Text] [Related]
17. Capecitabine plus cisplatin as first-line chemotherapy for advanced biliary tract cancer: a retrospective single-center study.
Woo SM; Lee WJ; Han SS; Park SJ; Kim TH; Koh YH; Kim HB; Hong EK; Park JW; Kim CM
Chemotherapy; 2012; 58(3):225-32. PubMed ID: 22831988
[TBL] [Abstract][Full Text] [Related]
18. [5 -fluoropyrimidines for treatment of biliary tract cancers].
Morizane C; Okusaka T; Ueno H; Ikeda M
Nihon Rinsho; 2006 Jan; 64 Suppl 1():529-33. PubMed ID: 16457319
[No Abstract] [Full Text] [Related]
19. Radiotherapy and concomitant intra-arterial docetaxel combined with systemic 5-fluorouracil and cisplatin for oropharyngeal cancer: a preliminary report--improvement of locoregional control of oropharyngeal cancer.
Oikawa H; Nakamura R; Nakasato T; Nishimura K; Sato H; Ehara S
Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):338-42. PubMed ID: 19735860
[TBL] [Abstract][Full Text] [Related]
20. A phase II study of docetaxel and oxaliplatin combination in recurrent gastric cancer patients after fluoropyrimidine and/or cisplatin adjuvant treatment: a Korean Cancer Study Group Protocol ST06-02.
Choi YH; Oh SC; Kim JS; Nam SH; Kim BS; Cho SH; Chung IJ; Song EK; Yim CY; Baek JH; Jeung HC; Hong YS; Yang SH; Kang HJ
Cancer Chemother Pharmacol; 2012 Nov; 70(5):665-72. PubMed ID: 22926638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]